Medical Condition News

RSS

Early human testing of iron chelation after brain bleed shows mixed results

A drug that removes excess iron and toxins from the body after a brain bleed did not show significant improvement in recovery or neurological function at three months after intracerebral hemorrhage (stroke), but showed some benefits at six months, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

11 Feb 2019

Bone marrow disease is stimulated by vitamin D and immune cells, reveals research

The bone marrow disease myelofibrosis is stimulated by excessive signaling from vitamin D and immune cells known as macrophages, reveals a Japanese research team. These findings could help to develop alternative treatments that do not target problem genes.

11 Feb 2019

Immunotherapy may be better than chemotherapy for Merkel cell carcinoma

The first study of the immunotherapy drug pembrolizumab as the initial treatment for patients with a rare but aggressive form of skin cancer known as Merkel cell carcinoma reports better responses and longer survival than expected with conventional chemotherapy.

11 Feb 2019

New heated tobacco device is as toxic as vaping and traditional cigarettes

A new study that directly compares new heated tobacco devices with vaping and traditional cigarettes shows that all three are toxic to human lung cells.

11 Feb 2019

New findings could provide novel approach to target and destroy cancer cells

An unexpected finding in pre-clinical platelet studies by Baker Institute researchers could provide a novel approach to targeting and destroying difficult-to-treat cancer cells, providing new therapeutic options for a range of cancers.

11 Feb 2019

New cancer drug that acts as ‘Trojan horse’ shows promise in patients with various cancers

A brand new type of cancer drug that acts as a 'Trojan horse' to get inside tumor cells has shown promise in patients with six different cancer types.

11 Feb 2019

Alzheimer's disease protection from exercise hormone irisin

Irisin is found to be protective against Alzheimer’s disease finds a new study. The results of the new study were published in the journal Nature Medicine.

11 Feb 2019

Home-based telerehab appears to be as effective as clinic-based therapy in restoring mobility

Home-based telerehabilitation is just as effective as clinic-based therapy at restoring arm function among stroke survivors, according to late-breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting dedicated to the science and treatment of cerebrovascular disease for researchers and clinicians.

11 Feb 2019

Research finds new potential targets for treatment of pancreatic cancer

The first study in the world to take a detailed look at scar tissue in human pancreatic cancer has revealed a range of different scar tissue types that could help clinicians predict which patients will respond best to particular treatments.

11 Feb 2019

Study reveals how exercise may protect against Alzheimer's disease

Athletes know a vigorous workout can release a flood of endorphins: "feel-good" hormones that boost mood. Now there's evidence that exercise produces another hormone that may improve memory and protect against Alzheimer's disease, according to a study co-led by Ottavio Arancio, MD, PhD, a researcher at Columbia University's Vagelos College of Physicians and Surgeons and Taub Institute for Research on Alzheimer's Disease and the Aging Brain.

11 Feb 2019

New research opens the way for tailored cancer drugs

New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer.

11 Feb 2019

Study finds low relapse risk in young patients with Hodgkin lymphoma

The treatment of Hodgkin lymphoma is now so effective that young patients who do not have a relapse within two years of therapy have a life expectancy similar to that of their healthy peers.

8 Feb 2019

'Trojan horse' drug shows promise for untreatable cancers

A new cancer drug that uses a ‘Trojan horse’ approach to destroy cancer cells from within has shown promising results for patients with untreatable cancers.

8 Feb 2019

Misinformation is causing measles cases to rise worldwide

Misinformation and anti-vaccination groups have caused a rise in cases of vaccine-preventable viral disease measles around the world, according to the WHO.

8 Feb 2019

Removing 70% or more of the brain hemorrhage could produce better outcomes, study finds

In the first study to identify specific surgical goals for the treatment of an intracerebral hemorrhage--the deadliest and most disabling type of stroke--a team of neurosurgeons found that at least 70 percent of the hemorrhage has to be removed for patients to make a meaningful recovery.

8 Feb 2019

Medical Condition News

Early human testing of iron chelation after brain bleed shows mixed results

Bone marrow disease is stimulated by vitamin D and immune cells, reveals research

Immunotherapy may be better than chemotherapy for Merkel cell carcinoma

New heated tobacco device is as toxic as vaping and traditional cigarettes

New findings could provide novel approach to target and destroy cancer cells

New cancer drug that acts as ‘Trojan horse’ shows promise in patients with various cancers

Alzheimer's disease protection from exercise hormone irisin

Home-based telerehab appears to be as effective as clinic-based therapy in restoring mobility

Research finds new potential targets for treatment of pancreatic cancer

Study reveals how exercise may protect against Alzheimer's disease

New research opens the way for tailored cancer drugs

Study finds low relapse risk in young patients with Hodgkin lymphoma

'Trojan horse' drug shows promise for untreatable cancers

Misinformation is causing measles cases to rise worldwide

Removing 70% or more of the brain hemorrhage could produce better outcomes, study finds

JUUL under scrutiny for raising nicotine levels in e-cigarettes

Unexpected discovery points to potential new treatment for autoimmune disorder

First step in tailoring rehabilitation and support services for young stroke survivors

Researchers report promising advance in the search for new class of antidepressants

Simple drug cocktail converts neighboring glial cells into functional new neurons

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News